Original Research
Published on 19 Dec 2019
Target-Dependent Expression of IL12 by synNotch Receptor-Engineered NK92 Cells Increases the Antitumor Activities of CAR-T Cells
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2019.01448
- 20,625 views
- 46 citations





